MVM adds Advent veteran to Boston office

UK VC MVM Life Science Partners has hired Dr Eric Bednarski as a partner in its Boston office as the firm prepares to launch its third life science fund, MVM Fund III.

Previously, Bednarski was a partner at Advent Healthcare Ventures, the spin-out of the life science venture team of Advent International, where he focused on investments in biopharmaceutical companies for over six years. He was a co-founder, CEO and board member of Advent portfolio companies Ampla Pharmaceuticals and Prexa Pharmaceuticals, and shared responsibility for Advent’s lead investments in Aegerion Pharmaceuticals and AlgoRx Pharmaceuticals now Anesiva).

Prior to joining Advent, Bednarski was director in the corporate finance group of Silicon Valley Bank where he provided M&A and finance advisory services to VC-backed life science companies.